Mr. Anzal Qurbain | Clinical Development Consultant
M
r. Anzal Qurbain is a UK-registered pharmaceutical physician with a full GMC licence to practise and an executive MBA from the London Business School. Passionate about medical affairs with 22 years of pharmaceutical industry experience, including 12 years as an ABPI and corporate-level final signatory.
Experienced board member with cross-functional international expertise in digital healthcare, medical affairs, new business development, clinical development, global safety risk management, compliance, and regulatory affairs.
Specialities:
CNS (Central Nervous System), Rare Diseases, Immunology, Respiratory
Pain, Osteoporosis, Dermatology, Anti-Infectives, Smoking Cessation, Oncology
Education :
- Executive MBA, Masters London Business School, London 2010 – 2012
- Medicine, MBBS
- Biological Sciences, BSc (Hons) Imperial College of Science, Technology & Medicine, London 1990 – 1996
- Faculty Of Pharmaceutical Medicine, MFPM (Hon) Honorary membership 2022
Experience :
- Senior Medical Affairs and Clinical Development Consultant (2014 – Present)
- Medical Director (Anti-Infectives, CNS, Pain, Respiratory) – GlaxoSmithKline (2003 – 2006)
- Drug Safety Physician (Oncology, Dermatology, GI) – Roche (2000 – 2003)
- Medical Advisor – MediTech Media (1999 – 2000)
- QPPV (CNS) – Merz Pharma (2008 – 2011)
- Medical Director (CNS & Aesthetics) – Merz Pharma (2006 – 2008)
- Medical Therapy Area Head (Respiratory) – Novartis (2012 – 2014)
- Senior Product Medical Advisor (CNS and GI) – Eisai (2011)
- Pfizer (Respiratory, Pain, Smoking, CNS and Primary Care)
Professional Membership
- Faculty Of Pharmaceutical Medicine (MFPM) – Honorary membership 2022
Technical Skills
- ABPI Final Medical Signatory
- Medical/Marketing Strategy
- Pharmacovigilance & Regulatory Affairs